• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.在纤维化硬皮病皮肤中,胶原蛋白转录抑制因子Fli1持续下调。
Am J Pathol. 2003 Aug;163(2):571-81. doi: 10.1016/S0002-9440(10)63685-1.
2
Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.硬皮病成纤维细胞中I型胶原蛋白表达增强与FLI1基因表观遗传抑制之间的关联。
Arthritis Rheum. 2006 Jul;54(7):2271-9. doi: 10.1002/art.21948.
3
Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects.硬皮病骨髓细胞中 Fli1 的下调具有成纤维细胞增生和促炎作用。
Front Immunol. 2020 May 19;11:800. doi: 10.3389/fimmu.2020.00800. eCollection 2020.
4
Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.波生坦通过增强转录因子Fli1的DNA结合能力来逆转系统性硬化症皮肤成纤维细胞的促纤维化表型。
Arthritis Res Ther. 2014 Apr 3;16(2):R86. doi: 10.1186/ar4529.
5
Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma.由于组成性激活的 c-Abl/PKC-δ/Fli1 通路导致颗粒蛋白前体过度产生,导致皮肤成纤维细胞对局部硬皮病中肿瘤坏死因子-α的抗纤维化作用产生抵抗。
J Dermatol Sci. 2018 Nov;92(2):207-214. doi: 10.1016/j.jdermsci.2018.09.005. Epub 2018 Sep 19.
6
Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin.转录因子Fli1调节小鼠皮肤中的胶原纤维形成。
Mol Cell Biol. 2009 Jan;29(2):425-34. doi: 10.1128/MCB.01278-08. Epub 2008 Nov 10.
7
Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.Fli1 缺乏可诱导真皮成纤维细胞和内皮细胞中 CXCL6 的表达,导致系统性硬化症中纤维化和血管病变的发生。
J Rheumatol. 2017 Aug;44(8):1198-1205. doi: 10.3899/jrheum.161092. Epub 2017 May 15.
8
Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.由于Fli1缺乏导致内皮细胞中chemerin表达增加,可能会促使系统性硬化症中出现指端溃疡。
Rheumatology (Oxford). 2015 Jul;54(7):1308-16. doi: 10.1093/rheumatology/keu479. Epub 2014 Dec 23.
9
Bushen Yijing Decoction (BSYJ) exerts an anti-systemic sclerosis effect via regulating MicroRNA-26a /FLI1 axis.补肾益精汤通过调节MicroRNA-26a/FLI1轴发挥抗系统性硬化症作用。
Bioengineered. 2021 Dec;12(1):1212-1225. doi: 10.1080/21655979.2021.1907128.
10
A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.组织蛋白酶L表达改变对系统性硬化症中皮肤纤维化和血管病变发展的潜在作用。
Exp Dermatol. 2016 Apr;25(4):287-92. doi: 10.1111/exd.12920. Epub 2016 Feb 11.

引用本文的文献

1
Role of Transcription Factor Fli-1 in Inflammation and Autoimmune Diseases.转录因子Fli-1在炎症和自身免疫性疾病中的作用
Biomolecules. 2025 Mar 25;15(4):480. doi: 10.3390/biom15040480.
2
Virus-Induced MicroRNA Modulation and Systemic Sclerosis Disease.病毒诱导的微小RNA调控与系统性硬化症
Biomedicines. 2024 Jun 19;12(6):1360. doi: 10.3390/biomedicines12061360.
3
The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity.系统性硬化症的发病机制:纤维化的起源及其与血管病变和自身免疫的关联
Int J Mol Sci. 2023 Sep 19;24(18):14287. doi: 10.3390/ijms241814287.
4
Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens.一种用于检测癌症组织标本中 ETV1 表达的 ETV1 兔单克隆抗体的开发和鉴定。
J Immunol Methods. 2023 Jul;518:113493. doi: 10.1016/j.jim.2023.113493. Epub 2023 May 16.
5
Fli1 and Tissue Fibrosis in Various Diseases.Fli1 在多种疾病中的组织纤维化作用。
Int J Mol Sci. 2023 Jan 18;24(3):1881. doi: 10.3390/ijms24031881.
6
Therapeutic molecular targets of SSc-ILD.系统性硬化症相关间质性肺疾病的治疗分子靶点。
J Scleroderma Relat Disord. 2020 Mar;5(2 Suppl):17-30. doi: 10.1177/2397198319899013. Epub 2020 Jan 22.
7
What can we learn from -deficient mice, new animal models of systemic sclerosis?我们能从系统性硬化症的新动物模型——缺陷小鼠身上学到什么?
J Scleroderma Relat Disord. 2018 Feb;3(1):6-13. doi: 10.1177/2397198318758221. Epub 2018 Apr 4.
8
Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease.抑制 Fli-1 可防止阿尔茨海默病中周细胞的丢失和认知缺陷。
Mol Ther. 2022 Apr 6;30(4):1451-1464. doi: 10.1016/j.ymthe.2022.01.023. Epub 2022 Jan 14.
9
Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis.由于 FLI1 缺陷导致的内皮细胞 CCR6 表达有助于系统性硬化症相关的血管病变。
Arthritis Res Ther. 2021 Nov 13;23(1):283. doi: 10.1186/s13075-021-02667-9.
10
Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma.Fli1 缺陷抑制皮肤树突状细胞的 RALDH1 活性及其相关调节性 T 细胞的诱导:在硬皮病中的可能作用。
Arthritis Res Ther. 2021 May 8;23(1):137. doi: 10.1186/s13075-021-02520-z.

本文引用的文献

1
Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis.硬皮病与Smads蛋白:功能失调的Smad家族动态变化最终导致纤维化。
Arthritis Rheum. 2002 Jul;46(7):1703-13. doi: 10.1002/art.10413.
2
Factors involved in the regulation of type I collagen gene expression: implication in fibrosis.参与I型胶原基因表达调控的因素:对纤维化的影响
Exp Biol Med (Maywood). 2002 May;227(5):301-14. doi: 10.1177/153537020222700502.
3
Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta.Ets1是转化生长因子β(TGF-β)信号通路的效应因子,也是TGF-β促纤维化作用的拮抗剂。
J Biol Chem. 2002 Jun 7;277(23):20399-408. doi: 10.1074/jbc.M200206200. Epub 2002 Mar 27.
4
Deficient Smad7 expression: a putative molecular defect in scleroderma.Smad7表达缺陷:硬皮病中一种可能的分子缺陷。
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3908-13. doi: 10.1073/pnas.062010399.
5
Molecular aspects of scleroderma.硬皮病的分子学方面
Front Biosci. 2002 Mar 1;7:d608-18. doi: 10.2741/A798.
6
Enhanced expression of the receptor for granulocyte macrophage colony stimulating factor on dermal fibroblasts from scleroderma patients.硬皮病患者皮肤成纤维细胞上粒细胞巨噬细胞集落刺激因子受体的表达增强。
J Rheumatol. 2002 Jan;29(1):94-101.
7
Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway.Fli-1通过依赖Sp1的途径抑制真皮成纤维细胞中I型胶原蛋白的产生。
J Biol Chem. 2001 Jun 15;276(24):20839-48. doi: 10.1074/jbc.M010133200. Epub 2001 Mar 16.
8
Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma.局限性硬皮病患者皮肤切片中真皮成纤维细胞中转化生长因子β受体的表达上调。
Arthritis Rheum. 2001 Mar;44(3):731-4. doi: 10.1002/1529-0131(200103)44:3<731::AID-ANR124>3.0.CO;2-U.
9
The role of Fli-1 in normal cell function and malignant transformation.Fli-1在正常细胞功能和恶性转化中的作用。
Oncogene. 2000 Dec 18;19(55):6482-9. doi: 10.1038/sj.onc.1204042.
10
Ets factors and regulation of the extracellular matrix.Ets 因子与细胞外基质的调控
Oncogene. 2000 Dec 18;19(55):6464-71. doi: 10.1038/sj.onc.1204043.

在纤维化硬皮病皮肤中,胶原蛋白转录抑制因子Fli1持续下调。

Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.

作者信息

Kubo Masahide, Czuwara-Ladykowska Joanna, Moussa Omar, Markiewicz Margaret, Smith Edwin, Silver Richard M, Jablonska Stefania, Blaszczyk Maria, Watson Dennis K, Trojanowska Maria

机构信息

Division of Rheumatology and Immunology and the Laboratory of Cancer Genomics, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

出版信息

Am J Pathol. 2003 Aug;163(2):571-81. doi: 10.1016/S0002-9440(10)63685-1.

DOI:10.1016/S0002-9440(10)63685-1
PMID:12875977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1868228/
Abstract

The molecular and cellular mechanisms that maintain proper collagen homeostasis in healthy human skin and are responsible for the dysregulated collagen synthesis in scleroderma remain primarily unknown. This study demonstrates that Fli1 is a physiological negative regulator of collagen gene expression in dermal fibroblasts in vitro and in human skin in vivo. This conclusion is supported by the analyses of mouse embryonic fibroblasts from Fli1(-/-), Fli1(+/-), and Fli1(+/+) mice. In cultured human and mouse fibroblasts Fli1 expression levels are inversely correlated with the collagen type I expression levels. These in vitro observations were validated in vivo. In healthy human skin Fli1 protein is expressed in fibroblasts and endothelial cells. Significantly, absence of Fli1 expression in individual fibroblasts correlates with elevated collagen synthesis. In contrast to healthy skin, Fli1 protein is consistently absent from fibroblasts and significantly reduced in endothelial cells in clinically involved scleroderma skin, which correlates with enhanced collagen synthesis in systemic sclerosis skin. This study supports the role of Fli1 as a suppressor of collagen transcription in human skin in vivo. Persistent down-regulation of Fli1 in scleroderma fibroblasts in vivo may directly contribute to uncontrolled matrix deposition in scleroderma skin.

摘要

在健康人体皮肤中维持适当胶原蛋白稳态以及导致硬皮病中胶原蛋白合成失调的分子和细胞机制,目前仍基本未知。本研究表明,Fli1在体外真皮成纤维细胞和体内人体皮肤中是胶原蛋白基因表达的生理性负调节因子。来自Fli1(-/-)、Fli1(+/-)和Fli1(+/+)小鼠的小鼠胚胎成纤维细胞分析支持了这一结论。在培养的人和小鼠成纤维细胞中,Fli1表达水平与I型胶原蛋白表达水平呈负相关。这些体外观察结果在体内得到了验证。在健康人体皮肤中,Fli1蛋白在成纤维细胞和内皮细胞中表达。值得注意的是,单个成纤维细胞中Fli1表达缺失与胶原蛋白合成增加相关。与健康皮肤相反,在临床受累的硬皮病皮肤中,成纤维细胞持续缺乏Fli1蛋白,内皮细胞中Fli1蛋白显著减少,这与系统性硬化症皮肤中胶原蛋白合成增强相关。本研究支持Fli1在体内人体皮肤中作为胶原蛋白转录抑制因子的作用。硬皮病成纤维细胞中Fli1在体内持续下调可能直接导致硬皮病皮肤中不受控制的基质沉积。